coronavirus vaccine after an “unexplained illness” in a study participant, the company said Monday.In a statement posted to its website, the company said the person’s illness is being reviewed and evaluated by the independent Data Safety Monitoring Board along with the company’s own physicians.
Johnson & Johnson’s single-dose COVID-19 vaccine candidate begins phase 3 trial The company assured that such “serious adverse events” are not uncommon in clinical trials.
It’s also not clear if the illness came from the vaccine candidate itself or from a placebo.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]“Adverse events — illnesses, accidents, etc. — even those that are serious, are an expected part of any clinical.